Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a ‘Real-Life’ Setting

SIMPLE SUMMARY: We identified non-small cell lung cancer (NSCLC) patients with brain metastases who were treated with immune checkpoint inhibitors at Karolinska University Hospital, Sweden and University Hospital of Heraklion, Greece from 2016 to 2019. We analyzed intracranial efficacies in the pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Skribek, Marcus, Rounis, Konstantinos, Makrakis, Dimitrios, Agelaki, Sofia, Mavroudis, Dimitris, De Petris, Luigi, Ekman, Simon, Tsakonas, Georgios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764720/
https://www.ncbi.nlm.nih.gov/pubmed/33321730
http://dx.doi.org/10.3390/cancers12123707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764720/
https://www.ncbi.nlm.nih.gov/pubmed/33321730
http://dx.doi.org/10.3390/cancers12123707

Ejemplares similares